RESUMO
INTRODUCTION: Because of the high mortality, potential limitations, and inherent adverse effects associated with conventional therapies, as well as extracorporeal membrane oxygenation, for persistent pulmonary hypertension of the newborn (PPHN), alternative modes of ventilatory support have been researched. There is anecdotal evidence that high-frequency flow interruption ventilation (HFFI) benefits neonates with severe air leak and lung diseases unresponsive to conventional ventilation, so we conducted a study to compare the hospital course, survival rate, and incidence of chronic lung disease of neonates with PPHN treated with hyperventilation (HV) and HFFI. METHODS: Enrolled in the study were 36 neonates who (1) were treated with HV and a fraction of inspired oxygen of 1.0 for PPHN, (2) had arterial partial pressure of oxygen (P(aO2)) values
Assuntos
Ventilação em Jatos de Alta Frequência/métodos , Ventilação de Alta Frequência/métodos , Síndrome da Persistência do Padrão de Circulação Fetal/terapia , Gasometria , Infecção Hospitalar/etiologia , Feminino , Ventilação em Jatos de Alta Frequência/efeitos adversos , Ventilação em Jatos de Alta Frequência/normas , Ventilação de Alta Frequência/efeitos adversos , Ventilação de Alta Frequência/normas , Humanos , Recém-Nascido , Terapia Intensiva Neonatal , Tempo de Internação/estatística & dados numéricos , Masculino , Síndrome da Persistência do Padrão de Circulação Fetal/sangue , Síndrome da Persistência do Padrão de Circulação Fetal/diagnóstico , Síndrome da Persistência do Padrão de Circulação Fetal/mortalidade , Análise de Sobrevida , Fatores de Tempo , Resultado do TratamentoRESUMO
Placing preterm infants suffering idiopathic apnea of prematurity on the VPS had an effect on the infants' respiratory effort and achieved a reduction in the number of apneic episodes secondary to central and mixed apnea. However, VPS offered no benefits in the reduction of obstructive apnea in this study population. Because central apnea has been reported as the predominant type of apnea and VPS is a nontoxic, noninvasive, and easy-to-implement method of alleviating central and mixed apnea types, it seems prudent to give VPS which has the stimulus characteristics to preterm infants experiencing apnea of prematurity before other treatment modalities currently in use are tried. Further studies are warranted to determine if VPS is effective in a continuous long-term treatment for apnea of prematurity, for example, until the end of apnea.
Assuntos
Apneia/terapia , Doenças do Prematuro/terapia , Estimulação Física , Feminino , Humanos , Recém-Nascido , Recém-Nascido Prematuro , Masculino , Resultado do TratamentoRESUMO
High-frequency flow interruption (HFFI) was used successfully to rescue three preterm infants with severe respiratory distress syndrome (RDS) whose clinical condition continued to deteriorate while on the conventional mechanical ventilation. Had the HFFI not been used, the survival chances might have been 25 per cent for Case 1 and 2, and 45.5 per cent for Case 3. A dramatic, immediate, and sustained improvement in ventilation and oxygenation was demonstrated once the critical frequency and amplitude of HFFI were established. Bronchopulmonary dysplasia which was already evidenced in one infant before the HFFI attempt was detected in two infants. This study demonstrates that HFFI is capable of achieving adequate gas exchange and improving survival in infants with severe RDS.